Owlstone Medical to Provide Breath Biomarker Services for 4D Pharma

News   Mar 08, 2017 | Original story from Owlstone Medical

 
Owlstone Medical to Provide Breath Biomarker Services for 4D Pharma
 
 
 

RELATED ARTICLES

First Ever Online Event Focused on Cannabis Science

News

Analytical Cannabis is pleased to announce that the final line-up of speakers for the first ever cannabis science online event, The Science of Cannabis 2017 has been confirmed.

READ MORE

New Software Allows Mobile Monitoring of Breathing Problems

News

Researchers have developed new software that makes it possible to use low-cost, thermal cameras attached to mobile phones to track how fast a person is breathing.

READ MORE

Agilent Announces Expanded Use of Cancer Diagnostic in the US

News

Agilent announced that the FDA has approved the cancer diagnostic known as PD-L1 IHC 28-8 pharmDx for use in cases of urothelial carcinoma (UC) and of squamous cell carcinoma of the head and neck (SCCHN).

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE